All Type of News
Added-on dispensing charges backfires
The added-on dispensing charge system at pharmacy, which has been introduced in 2001, has drawn negative responses from most consumers.
The system is designed to compensate the pharmacies with night-time serve at w...
DreamCIS, ASKLEP signs strategic partnership agreement
DreamCIS Inc. Korea’s largest CRO and ASKLEP Inc. a Japan CRO, announced on January 30 that the two companies have signed a strategic partnership agreement to provide reciprocal clinical research services in their res...
KIPO to work With KAIST on intellectual property
The Korean Intellectual Property Office (KIPO) said it has agreed with the KAIST to work together in areas of nurturing entrepreneurs and intellectual property professionals.
The KIPO said it signed a memorandum of...
Hong Um-ki named executive managing director of Abbott Korea
Abbott Korea, a Korean unit of Abbott Laboratories, said that it has appointed Hong Um-ki as a new executive managing director as of February 3.
Hong, 51, will be responsible for personal management affairs.
A g...
Deregulation to Pick Up Speed
The new government, which has vowed to give top priority to reviving the sagging local economy by fostering a more business-friendly local environment, will go ahead with drastic deregulation measures to cut regulator...
Doctors protest drug substitution bill
Doctors have vehemently opposed a bill designed to grant an incentive system to pharmacists who will use generics for an original brand product.
The Korean Medical Association (KMA), the nation's largest group of d...
KFDA approves 26 Stillen generics
Dong-A Pharm’s Stillen, is unlikely to become a cash cow product as a total of 26 drug manufacturers, including Chong Kung Dang Pharmaceutical, Dongwha Pharm and Kwagdong, obtained a nod for Stillen generics from the ...
Health insurance covers Exelon patch
Novartis Korea said that Exelon Patch (rivastigmine transdermal patch), the first transdermal therapy for mild-to-moderate Alzheimer's disease, has been included in a list of insurance-covered medicines from February ...
Concerns growing over government’s price cut
There are mounting concerns over the government’s pressure to lower drug costs, although some large pharmaceutical firms, such as Yuhan Corporation, Hanmi Pharm, Green Cross Corporation and Chong Kun Dang Pharmaceutic...
Korean drugmakers urged to develop biosimilars
Domestic pharmaceutical firms will need to focus on development of promising biosimilars or similar biologics, considering the lack of money and resources to develop new drugs, according to market experts.
Unlike t...
